142 filings
Page 3 of 8
EFFECT
78s1kgr 458w5v
27 Mar 23
Notice of effectiveness
12:15am
ARS
yftss
22 Mar 23
Annual report to shareholders
4:22pm
DEFA14A
v7laugq8bv0q
22 Mar 23
Additional proxy soliciting materials
4:18pm
DEF 14A
9rpy 2ent
22 Mar 23
Definitive proxy
4:16pm
POS AM
owawrkdi
21 Mar 23
Prospectus update (post-effective amendment)
4:07pm
424B3
pw0s5u5e1bepka4h
7 Mar 23
Prospectus supplement
4:25pm
8-K
o42ln12cna
7 Mar 23
Akili Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
4:13pm
424B3
ihjj99 ro
12 Jan 23
Prospectus supplement
8:13am
8-K
ohwvkoaenf3lmq0
12 Jan 23
Cost Associated with Exit or Disposal Activities
8:06am
424B3
fhbdpg23cby5yqz1rjib
5 Jan 23
Prospectus supplement
7:21am
8-K
i3u1y62gr58 ykub
5 Jan 23
Pivotal Trial of EndeavorRx® in Adolescents with ADHD Shows Robust Improvements in Attention and Broader Clinical Outcomes
7:14am
8-K/A
f7e yfj7qhfwl3
27 Dec 22
Entry into a Material Definitive Agreement
9:19am
8-K
c8jnjt6dkykd8g cj
23 Dec 22
Entry into a Material Definitive Agreement
4:12pm
424B3
19a61so37
14 Nov 22
Prospectus supplement
4:11pm
424B3
0n5kefhuqnkug8rj5
10 Nov 22
Prospectus supplement
4:15pm
8-K
lp6upbew
10 Nov 22
Akili Reports Third Quarter 2022 Financial Results and Company Update
4:08pm
S-8
gu0ib99 tgv58
27 Oct 22
Registration of securities for employees
5:17pm
8-K
q5qjfu902
27 Oct 22
Financial Industry Veteran Mary Hentges Joins Akili’s Board of Directors
7:10am